(Q35639968)

9 August 2017

Proliferative activity in primary breast carcinomas is a salient prognostic factor (English)

1 reference

9 August 2017

Jean-Jacques Michels

1

1 reference

9 August 2017

Jacques Marnay

2

1 reference

9 August 2017

Thierry Delozier

3

1 reference

9 August 2017

Yves Denoux

4

1 reference

9 August 2017

Jacques Chasle

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

100

1 reference

9 August 2017

455-464

1 reference

9 August 2017

3

1 reference

Systemic adjuvant therapy for node-negative breast cancer: proven or premature?

9 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

Flow cytometric DNA analysis as prognostic factor in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Proj

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

The identification of informative parameters in the flow cytometric analysis of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prognostic significance of proliferative activity and ploidy in node-negative breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

S-phase fraction and nuclear size in long term prognosis of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

S-phase fraction is a prognostic factor in stage I breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

S-phase fraction and breast cancer--a decade of experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prediction of early course of breast carcinoma by thymidine labeling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Mitotic counts provide additional prognostic information in grade II mammary carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11916

7 January 2021

Identifiers

DOI

10.1002/CNCR.11916

1 reference

release_fgdpqwwarfc6rf255g7di64lge

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fgdpqwwarfc6rf255g7di64lge

24 November 2022

mapped directly with Wikidata item

1 reference